LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost of $90.13 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost $90.13M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost $237.47M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost $195.20M.
- 2025-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost $6.08M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost |
|---|---|
| 2026-06-30 | $90.13M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $237.47M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $195.20M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $6.08M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.71M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $4.65M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $14.06M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $18.36M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $6.97M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.85M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $10.90M 10-Q · filed 2023-05-08 |
| 2022-09-30 | $982.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.23M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.52M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $23.36M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $23.29M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $23.49M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $21.84M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $73.58M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $73.64M 10-Q · filed 2020-05-08 |